The lack of biomarkers for the immune dysregulation that underlies rheumatoid arthritis is hampering further advances in the management of the disease, an international expert says. Professor John Isaacs told the APLAR-ARA meeting that rheumatologists are good at diagnosing the disease by measuring CRP and imaging but that these are consequences of the disease not ...
Rheumatoid arthritis: lack of biomarkers a barrier to early management
By Mardi Chapman
15 Apr 2019